Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Nitrosamine

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,060Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 1, 2025
    Enforcement Report - Week of January 1, 2025

    01 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-1-2025-88420.pdf

    FDA
    01 Jan 2025
    Share Share
    Addressing Nitrosamine Risks in Pharmaceutical Manufacturing
    Addressing Nitrosamine Risks in Pharmaceutical Manufacturing

    10 Oct 2024

    // PRESS RELEASE

    https://www.api.polpharma.com/articles/addressing-nitrosamine-risks-in-pharmaceutical-manufacturing

    PRESS RELEASE
    10 Oct 2024
    Share Share
    Aptar's N-Sorb Accepted To FDA's Emerging Technology Program
    Aptar's N-Sorb Accepted To FDA's Emerging Technology Program

    23 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240923964121/en

    BUSINESSWIRE
    23 Sep 2024
    Share Share
    Nitrosating Agent Mitigation Strategy
    Nitrosating Agent Mitigation Strategy

    29 Aug 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_experts-opinion/2024-08-29/nitrosating-agent-mitigation-strategy/?widget=listSection

    CONTRACT PHARMA
    29 Aug 2024
    Share Share
    EMA seeks feedback on revised guideline on the chemistry of active substances
    EMA seeks feedback on revised guideline on the chemistry of active substances

    01 Aug 2024

    // RAPS

    https://www.raps.org/News-and-Articles/News-Articles/2024/8/Euro-Roundup-EMA-seeks-feedback-on-revised-guideli

    RAPS
    01 Aug 2024
    Share Share
    N-Nitroso Duloxetine Analytical Method Published in ACS Omega
    N-Nitroso Duloxetine Analytical Method Published in ACS Omega

    15 Mar 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/info/pdf/release240315.pdf

    PRESS RELEASE
    15 Mar 2024
    Share Share